Indication
Relapsing polychondritis
2 clinical trials
1 product
3 drugs
Clinical trial
A Pilot Study of Low Dose IL-2 in the Treatment of Relapsing PolychondritisStatus: Completed, Estimated PCD: 2023-10-10
Drug
IL-2Clinical trial
Biologics in Refractory Vasculitis (BIOVAS): A Pragmatic, Randomised, Double-blind, Placebo-controlled, Modified-crossover Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis in Adults and ChildrenStatus: Active (not recruiting), Estimated PCD: 2023-11-30
Drug
R-CHOPProduct
InfliximabDrug
Tocilizumab